Source: Annual Congress 2009 - New drugs for airways disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Rybacka-Chabros, J. Niedzwiadek (Lublin, Poland). Anti-inflammatory activity of low molecular weight heparin in patients with exacerbations of COPD. Eur Respir J 2009; 34: Suppl. 53, 1805

Member's Comments

No comment yet.

Related content which might interest you: Possible anti-inflammatory activity of low molecular weight heparin in patients with high risk of pulmonary embolism Source: Eur Respir J 2004; 24: Suppl. 48, 684s Year: 2004 Effect of roflumilast on exacerbations in patients with severe COPD and a prior history of hospitalization taking combination therapy Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 Effect of carbocysteine lysine salt on frequency of exacerbations in COPD patient treated with or without inhaled steroids Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Monitoring antioxidant enzyme activity in patients with COPD exacerbations Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 Possible anticoagulant effect of exacerbations on COPD Source: Eur Respir J 2004; 24: Suppl. 48, 542s Year: 2004 Both moderate and severe exacerbations accelerate physical activity decline in COPD patients Source: Eur Respir J, 51 (1) 1702110; 10.1183/13993003.02110-2017 Year: 2018 Increased platelet reactivity during acute exacerbations of COPD, irrespective of antiplatelet therapy Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Erdosteine improves airflow in patients with severe exacerbation of COPD (AECOPD) Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 The effects of physical activity coaching in patients with COPD after an acute exacerbation Source: International Congress 2014 – Exercise training and physical activity in patients with COPD Year: 2014 Effect of low dose theophylline as adjunct in treatment of COPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 The effect on mortality of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A focus on the frequent exacerbator phenotype Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015 Pharmacologic treatment of exacerbations of COPD Source: International Congress 2016 – Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society (ERS/ATS) guideline Year: 2016 Physical activity and exercise capacity in patients with moderate COPD exacerbations Source: Eur Respir J 2016; 48: 340-349 Year: 2016 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Positive outcomes of 900 mg daily erdosteine in acute exacerbation of COPD Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Ceruloplasmine efficacy in patients with asthma exacerbations Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011 Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Increased interferon and decreased NRF2-PPARG signaling is associated with frequent exacerbations in COPD Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 Physical activity and the use of COPD medication Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases Year: 2015 Therapeutic effect of low dose roxithromycin in chronic stable mild-to-moderate asthma Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010